TrialBMJ open gastroenterology2023

Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis.

Marla C Dubinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.